Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s468825 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Yang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry of People's Rep…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Pulmonary Disease, Chronic Obstructive, Oxidative Stress, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Foundation of the Department of Science and Technology of HeNan Province.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry of People's Republic of China, Henan University of Chinese Medicine, Zhengzhou, Peopl…
- School of Basic Medicine (Zhongjing School), Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
- Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
- First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
ORCID-Profile: Yang Liu, Jiansheng Li
Förderung
- National Natural Science Foundation of China
- Foundation of the Department of Science and Technology of HeNan Province
Zitieren
APA
Liu, Y., Zhang, L., Zhao, J., Lu, R., Shao, X., Xu, K., Li, J., & Tian, Y. (2024). Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s468825
Vancouver
Liu Y, Zhang L, Zhao J, Lu R, Shao X, Xu K, et al. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s468825
BibTeX
@article{Liu2024,
author = {Liu, Yang and Zhang, Lanxi and Zhao, Jie and Lu, Ruilong and Shao, Xuejie and Xu, Kexin and Li, Jiansheng and Tian, Yange},
title = {Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s468825}
}
EUVIMED